🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will treat patients with advanced NSCLC who have already receive...
Status
Completed
Location
Research Site
Start Date
2013-03-04
Trial ID
NCT01802632
Treatments Being Tested
Patients will receive AZD9291 at a dose of 80 mg once daily. Intracranial r...
Status
Unknown
Location
Shaare Zedek
Start Date
2016-05
Trial ID
NCT02736513
Treatments Being Tested
Multinational, multi-center medical record review to describe the treatment...
Status
Completed
Location
Research Site
Start Date
2019-05-07
Trial ID
NCT04031898
Treatments Being Tested
The study is being done to determine if non-invasive testing (urine and pla...
Status
Completed
Location
Research Site
Start Date
2017-10-24
Trial ID
NCT03137264
Treatments Being Tested
The aim of this study is to evaluate concordance of T790M mutation plasma t...
Status
Completed
Location
Research Site
Start Date
2016-12-23
Trial ID
NCT02997501
In the management of non-small cell lung cancer of the adenocarcinoma type,...
Status
Completed
Location
University Hospital
Start Date
2017-07-01
Trial ID
NCT04546282
This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-08-17
Trial ID
NCT02465060
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability and prel...
Status
Active Not Recruiting
Location
Research Site
Start Date
2014-08-05
Trial ID
NCT02143466
Treatments Being Tested
This trial is divided into Part A and Part B. The primary objective of Part...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2012-07
Trial ID
NCT01647711
Treatments Being Tested
The main objective of this study is to evaluate the safety and tolerability...
Status
Completed
Location
Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences
Start Date
2016-12-29
Trial ID
NCT02914990
Treatments Being Tested